These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 1438243)

  • 1. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
    Wild C; Oas T; McDanal C; Bolognesi D; Matthews T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10537-41. PubMed ID: 1438243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Wild CT; Shugars DC; Greenwell TK; McDanal CB; Matthews TJ
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9770-4. PubMed ID: 7937889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
    Wild C; Dubay JW; Greenwell T; Baird T; Oas TG; McDanal C; Hunter E; Matthews T
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12676-80. PubMed ID: 7809100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.
    Jiang S; Lin K; Strick N; Neurath AR
    Biochem Biophys Res Commun; 1993 Sep; 195(2):533-8. PubMed ID: 8373393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.
    Jin BS; Ryu JR; Ahn K; Yu YG
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1797-804. PubMed ID: 11118065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
    Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
    Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.
    Piñón JD; Kelly SM; Price NC; Flanagan JU; Brighty DW
    J Virol; 2003 Mar; 77(5):3281-90. PubMed ID: 12584351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of antiviral activity with beta-turn types for V3 synthetic multibranched peptides from HIV-1 gp120.
    Mabrouk K; Van Rietschoten J; Rochat H; Loret EP
    Biochemistry; 1995 Jul; 34(26):8294-8. PubMed ID: 7599121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein.
    Schmidtmayerova H; Gayet O; Guettari N; Bolmont C; Hirsch I; Chermann JC
    Res Virol; 1993; 144(1):21-6. PubMed ID: 8446773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.
    Bahbouhi B; Chazal N; Seidah NG; Chiva C; Kogan M; Albericio F; Giralt E; Bahraoui E
    Biochem J; 2002 Sep; 366(Pt 3):863-72. PubMed ID: 12071862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
    Srinivas SK; Srinivas RV; Anantharamaiah GM; Segrest JP; Compans RW
    J Biol Chem; 1992 Apr; 267(10):7121-7. PubMed ID: 1551918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death.
    Callebaut C; Jacotot E; Guichard G; Krust B; Rey-Cuille M; Cointe D; Benkirane N; Blanco J; Muller S; Briand J; Hovanessian AG
    Virology; 1996 Apr; 218(1):181-92. PubMed ID: 8615021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.
    Lombardi S; Massi C; Indino E; La Rosa C; Mazzetti P; Falcone ML; Rovero P; Fissi A; Pieroni O; Bandecchi P; Esposito F; Tozzini F; Bendinelli M; Garzelli C
    Virology; 1996 Jun; 220(2):274-84. PubMed ID: 8661378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity of linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein: synthesis, reoxidation and purification.
    Belhadj Jrad B; Bahraoui E
    J Pept Res; 1998 May; 51(5):370-85. PubMed ID: 9606017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral envelope glycoprotein processing: structural investigation of the cleavage site.
    Moulard M; Chaloin L; Canarelli S; Mabrouk K; Darbon H
    Biochemistry; 1998 Mar; 37(13):4510-7. PubMed ID: 9521771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
    Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and activity evaluation of novel peptide fusion inhibitors targeting HIV-1 gp41.
    Tan J; Su M; Zeng Y; Wang C
    Bioorg Med Chem; 2016 Jan; 24(2):201-6. PubMed ID: 26706116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.
    Slepushkin VA; Kornilaeva GV; Andreev SM; Sidorova MV; Petrukhina AO; Matsevich GR; Raduk SV; Grigoriev VB; Makarova TV; Lukashov VV
    Virology; 1993 May; 194(1):294-301. PubMed ID: 7683157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.